Hartland & Co »

Atea Pharmaceuticals shares owned by Hartland & Co

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Hartland & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $102 22 4.68

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Apple Put Put Option (Principal) (AAPL)
Paccar (PCAR)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Index Shs Fds St Str Po Ex Etf (SPDW)
Amazon Call Call Option (AMZN)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Ishares Tr Core Msci Intl (IDEV)
Vanguard Index Fds Call Call Option (VTI)

View all positions for Hartland & Co

Top funds holding Atea Pharmaceuticals

FMR
BlackRock
BML Capital Management
Tang Capital Management
Vanguard Capital Management
Bain Capital Life Sciences Investors
Acadian Asset Management
Geode Capital Management
State Street Corporation
Two Sigma Investments
Dimensional Fund Advisors
Renaissance Technologies
Rosalind Advisors
Jpmorgan Chase & Co
Northern Trust

View all funds holding Atea Pharmaceuticals